Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Syndax Pharmaceuticals In...

    NASDAQ: SNDX · Real-Time Price · USD
    9.97
    -0.28 (-2.73%)
    At close: Jun 16, 2025, 3:59 PM
    9.99
    0.15%
    After-hours: Jun 16, 2025, 05:45 PM EDT

    Syndax Pharmaceuticals Statistics

    Share Statistics

    Syndax Pharmaceuticals has 86.05M shares outstanding. The number of shares has increased by 1.22% in one year.

    Shares Outstanding

    n/a
    		 86.05M

    Shares Change (YoY)

    n/a
    		 1.22%

    Shares Change (QoQ)

    n/a
    		 0.78%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 82.47M

    Failed to Deliver (FTD) Shares

    n/a
    		 7,566

    FTD / Avg. Volume

    n/a
    		 0.35%

    Short Selling Information

    The latest short interest is 23.14M, so 26.89% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 23.14M

    Short % of Shares Out

    n/a
    		 26.89%

    Short % of Float

    n/a
    		 30.37%

    Short Ratio (days to cover)

    n/a
    		 8.6

    Valuation Ratios

    The PE ratio is -3.55 and the forward PE ratio is -3.79. Syndax Pharmaceuticals's PEG ratio is -0.14.

    PE Ratio

    n/a
    		 -3.55

    Forward PE

    n/a
    		 -3.79

    PS Ratio

    n/a
    		 47.8

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 3.93

    P/FCF Ratio

    n/a
    		 -4.12

    PEG Ratio

    n/a
    		 -0.14
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Syndax Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.82, with a Debt / Equity ratio of 1.2.

    Current Ratio

    n/a
    		 5.82

    Quick Ratio

    n/a
    		 5.82

    Debt / Equity

    n/a
    		 1.2

    Debt / EBITDA

    n/a
    		 -1.1

    Debt / FCF

    n/a
    		 -1.26

    Interest Coverage

    n/a
    		 -68.91

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $87,703.7

    Profits Per Employee

    n/a
    		 $-1,180,585.19

    Employee Count

    n/a
    		 270

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 2.26

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -49.85% in the last 52 weeks. The beta is 0.74, so Syndax Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.74

    52-Week Price Change

    n/a
    		 -49.85%

    50-Day Moving Average

    n/a
    		 11.22

    200-Day Moving Average

    n/a
    		 14.88

    Relative Strength Index (RSI)

    n/a
    		 40.78

    Average Volume (20 Days)

    n/a
    		 2,168,560

    Income Statement

    In the last 12 months, Syndax Pharmaceuticals had revenue of 23.68M and earned -318.76M in profits. Earnings per share was -3.73.

    Revenue

    n/a
    		 23.68M

    Gross Profit

    n/a
    		 22.85M

    Operating Income

    n/a
    		 -339.67M

    Net Income

    n/a
    		 -318.76M

    EBITDA

    n/a
    		 -313.82M

    EBIT

    n/a
    		 -313.83M

    Earnings Per Share (EPS)

    n/a
    		 -3.73
    Full Income Statement

    Balance Sheet

    The company has 154.08M in cash and 345.74M in debt, giving a net cash position of -191.66M.

    Cash & Cash Equivalents

    n/a
    		 154.08M

    Total Debt

    n/a
    		 345.74M

    Net Cash

    n/a
    		 -191.66M

    Retained Earnings

    n/a
    		 -1.22B

    Total Assets

    n/a
    		 640.71M

    Working Capital

    n/a
    		 454.2M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -274.9M and capital expenditures 0, giving a free cash flow of -274.9M.

    Operating Cash Flow

    n/a
    		 -274.9M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -274.9M

    FCF Per Share

    n/a
    		 -3.21
    Full Cash Flow Statement

    Margins

    Gross margin is 96.51%, with operating and profit margins of -1434.43% and -1346.11%.

    Gross Margin

    n/a
    		 96.51%

    Operating Margin

    n/a
    		 -1434.43%

    Pretax Margin

    n/a
    		 -1346.11%

    Profit Margin

    n/a
    		 -1346.11%

    EBITDA Margin

    n/a
    		 -1325.26%

    EBIT Margin

    n/a
    		 -1434.43%

    FCF Margin

    n/a
    		 -1160.91%

    Dividends & Yields

    SNDX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SNDX is $37, which is 271.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $37

    Price Target Difference

    n/a
    		 271.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 11
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist